Is Genpact (G) a Great Value Stock Right Now?

09.01.25 15:40 Uhr

Werte in diesem Artikel
Aktien

42,57 EUR -0,21 EUR -0,49%

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One stock to keep an eye on is Genpact (G). G is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock has a Forward P/E ratio of 12.41. This compares to its industry's average Forward P/E of 25.01. G's Forward P/E has been as high as 13.92 and as low as 9.75, with a median of 11.32, all within the past year.Investors will also notice that G has a PEG ratio of 1.26. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. G's industry has an average PEG of 2.64 right now. G's PEG has been as high as 1.66 and as low as 1.23, with a median of 1.36, all within the past year.Finally, we should also recognize that G has a P/CF ratio of 10.10. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. G's current P/CF looks attractive when compared to its industry's average P/CF of 16.92. Within the past 12 months, G's P/CF has been as high as 11.03 and as low as 7.46, with a median of 8.72.These figures are just a handful of the metrics value investors tend to look at, but they help show that Genpact is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, G feels like a great value stock at the moment.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Genpact Limited (G): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Genpact

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Genpact

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Genpact LtdShs

Wer­bung

Analysen zu Genpact LtdShs

DatumRatingAnalyst
08.08.2019Genpact BuyNeedham & Company, LLC
14.06.2019Genpact BuyNeedham & Company, LLC
04.08.2017Genpact Market PerformBMO Capital Markets
04.08.2017Genpact NeutralWedbush Morgan Securities Inc.
11.04.2016Genpact UnderperformRBC Capital Markets
DatumRatingAnalyst
08.08.2019Genpact BuyNeedham & Company, LLC
14.06.2019Genpact BuyNeedham & Company, LLC
04.08.2017Genpact Market PerformBMO Capital Markets
29.08.2011Genpact outperformOppenheimer & Co. Inc.
19.05.2011Genpact outperformOppenheimer & Co. Inc.
DatumRatingAnalyst
04.08.2017Genpact NeutralWedbush Morgan Securities Inc.
02.03.2015Genpact HoldDeutsche Bank AG
05.02.2015Genpact HoldDeutsche Bank AG
DatumRatingAnalyst
11.04.2016Genpact UnderperformRBC Capital Markets
30.07.2010Genpact sellKaufman Bros., LP

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Genpact LtdShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"